home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Events -> Meetings and Conferences  

Potency determination of drugs and biologics: design, and development of reliable potency bioassays

  March 24, 2010  

Complianceonline, Online Web Event

This potency bioassays training will helps you in understanding how to design and development of assays to measure potency, key validation parameters, and specifications. Problems due to method variability and its impact on accuracy of potency measurements, and relevant case studies will be discussed.

Why Should You Attend:

Potency of all drugs and biologics is a requisite characteristic of pre-clinical and clinical grade materials for regulatory agencies. In some cases, the detailed mechanism of action of many drugs and biologics are either relatively obscure or under investigation, and obviate the protective attributes of the drug candidate. Therefore, potency measurements are considered a reliable indicator of therapeutic potential and also an indicator of physio-chemical and immunological integrity of a therapeutic candidate during product release and stability testing. The methods and optimization of potency assays can evolve during phases of drug development, and in conjunction with an accruing scientific and clinical knowledge-base on the targeted disease condition, and the therapeutic candidate.

This webinar will provide a comprehensive overview of potency. The design and development of assays to measure potency, key validation parameters, and specifications will be addressed. Problems due to method variability, the impact on accuracy of potency measurements, and relevant case studies will be discussed. The comprehensive guidelines of regulatory agencies including the Food and Drug Administration (FDA), the International Conference on Harmonization (ICH), and the Committee for Medicinal Products for Human Use (CHMP)/ the European Medicines Agency will be covered.

Areas Covered in the Seminar:
  • Bioassay selection for screening of the drug or biologic.
  • Preparation of GMP cell banks.
  • Validation parameters and specifications for accuracy and precision.
  • Regulatory guidelines on potency; FDA, ICH, CHMP, EMEA.
  • Potential problems, and control strategies.
  • Case studies.
Organized by: ComplianceOnline
Invited Speakers: Chitra Edwin, Ph.D., RAC., Principal, Biotechnology Consulting Solutions, Ltd. has over 15 years of product development and management experience in start-ups, mid-sized and large biotechnology and diagnostic companies. She has managed projects from concept, R&D through manufacturing transfer, and has been involved in the development of approved products. She has successfully established regulatory compliant laboratories, managed multidisciplinary project teams, executed technology transfers, and orchestrated collaborations between national and international professionals. Dr. Edwin’s responsibilities have included pre-clinical evaluations of therapeutic biologics, vaccines and diagnostics. She has functioned as a facilitator between academia and industry that culminated in contractual service agreements, and organized professional meetings with representatives from academia and industry.
Deadline for Abstracts: Call contact
Online Event
EVENT INFORMATION: Contact Admin, Phone: +1-650-620-3915, Fax number: +1-650-963-2556
E-mail: admin@complianceonline.com
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.